Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Proposals of the Shareholders’ Nomination Board to Neste’s Annual General Meeting

Neste Corporation, Stock Exchange Release, 31 January 2024 at 8:30 a.m. (EET) The Shareholders' Nomination Board, established by Neste Corporation's Annual General Meeting (AGM) on 4 April 2013, has forwarded to the Board of Directors of the Company its proposals to the 2024 AGM.  Board Members The Nomination Board proposes that Matti Kähkönen shall be re-elected as the Chair of the Board of Directors. In addition, the current members of the Board, John Abbott, Nick Elmslie, Just Jansz, Heikki Malinen, Eeva Sipilä and Johanna Söderström are proposed to be re-elected for a further

Year-end report: Strong cash flow despite weak European market

The fourth quarter · Revenue was SEK 26,469 (30,138) million · Adjusted operating result was SEK 2,400 (3,768) million · Adjusted earnings per share were SEK 1.86 (3.18) · Net cash was SEK 18.2 (14.3) billion · The Board proposes a dividend of SEK 5.00 (8.70) per share   Full-year 2023 · Revenue was SEK 119,489 (128,745) million · Adjusted operating result was SEK 16,467 (29,283) million · Earnings per share was SEK 12.67 (-10.57)Comments by the CEO SSAB's adjusted operating result for the fourth quarter of 2023 amounted to SEK 2,400 (3,768) million and

PRH has deregistered companies that have not filed their financial statements for registration

The Finnish Patent and Registration Office (PRH) has removed from the Finnish Trade Register circa 600 limited liability companies and co-operatives that have not filed their financial statements for registration. Deregistration means that the business is out of action.The deregistered companies had not filed their financial statements despite reminder letters. The PRH had also informed the companies of the procedure using a number of communication channels. See the list of the companies deregistered on 30 January 2024 on the prh.fi website:   · Read more about the deregistered

Change in number of shares and votes in Camurus

Lund, Sweden — 31 January 2024 — As previously announced, Camurus has carried out a directed share issue. The directed share issue has resulted in a change in the number of shares and votes in Camurus as follows: Prior to the directed share issue, the total number of shares in Camurus amounted to 55,623,618, corresponding to 55,623,618 votes. The number of shares and votes has as a result of the directed share issue increased by 2,000,000 shares and votes. As of 31 January 2024, the total number of shares in Camurus amounts to 57,623,618, corresponding to 57,623,618 votes. For more

Nightingale Health receives five new patents for its proprietary health risk detection capability

Nightingale Health Plc, Press release, 31 January 2024 at 8:00 a.m. (EET) Nightingale Health Plc (“Nightingale Health”), a pioneer in health risk detection and preventative health, has received five new patents from the Finnish Patent and Registration Office. Nightingale Health announced during 2023 that it had received nine patents, and with these five new patents the company’s patent portfolio expands to cover additional health areas such as infectious diseases and anemia. The first of the newly received patents was granted for the company’s proprietary technology’s ability to

Sobi to present new data at EAHAD 2024

Sobi® will present new data at the 17th European Association of Haemophilia and Allied Disorders (EAHAD) conference in Frankfurt from 6-9 February 2024. The studies that will be presented support Sobi's ongoing commitment to evolving treatment options for people with haemophilia.“We are proud to showcase new data at EAHAD 2024, including several new data sets that add to the substantial evidence supporting the use of efanesoctocog alfa in children and highlighting improvements in patient-reported outcomes. Our hope is that these advancements will open new possibilities for people with

SKF Year-end report 2023: Strategy execution yielding strong performance

Gothenburg, 31 January 2024 Q4 2023 Net sales: SEK 24,438 million (25,361) Organic growth: -1.9% (9.7%) Adjusted operating profit/margin: SEK 2,929 million, 12.0% (2,542, 10.0%) Full year 2023 Net sales: SEK 103,881 million (96,933) Organic growth: 3.7% (8.1%) Adjusted operating profit/margin: SEK 12,977 million, 12.5% (10,204, 10.5%) Rickard Gustafson, President and CEO: “We have diligently executed on our strategy throughout 2023 to further strengthen us as a company. This strategic transformation has made us more resilient and competitive also in the weaker demand

Limoneira Moves Forward with Deployment of LNC for Climate Smart Lemon Farming in Yuma, Arizona

Sandnes, Norway, 31 January 2024 – Desert Control is proud to announce that Limoneira Company, a Delaware corporation (“Limoneira”), following two years of successful pilot trials, is advancing with commercial deployment of Liquid Natural Clay (“LNC”) at their citrus ranch in Yuma, Arizona. This move underscores Limoneira's dedication to pioneering sustainable agricultural practices and marks a significant step in the commercial market adoption of LNC. Desert Control, on 31 January 2024, received a purchase order from Limoneira to apply LNC for an additional 6,652 trees over 60 acres at

Continued strong growth in the quarter – EBITDA increased by 42 percent

FOURTH QUARTER OCTOBER-DECEMBER     · The Group’s net sales amounted to SEK 456.6 (322.8) million, an increase of 41 percent. · The Group’s EBITDA was SEK 104.5 (73.3) million, an increase of 42 percent. · The EBITDA margin was 23 (23) percent. · Profit after tax amounted to SEK 62.2 (40.5) million. · Earnings per share amounted to SEK 4.2 (2.7). · Cash flow from operating activities was SEK 74.7 (-39.1) million. TWELVE MONTHS JANUARY-DECEMBER · The Group’s net sales amounted to SEK 1,587.4 (1,111.3) million, an increase of 43 percent. · The Group’s EBITDA was

Europe must take action to revive its competitiveness

Press release, January 31, 2024 Turbulent times have highlighted new fragilities in Europe’s economies. Addressing them could be the catalyst for a new wave of competitiveness and growth, according to McKinsey's new report "Accelerating Europe: Competitiveness for a new era". Europe is one of the world’s leading regions in terms of sustainability and inclusion, but its per capita income remains 27 percent lower than in the United States. Closing that prosperity gap depends on accelerating growth by becoming more globally competitive. "If Europe fails to improve its

ESGFIRE comments on Ekobots new partnership with Väderstad AB

Company: EkobotListings: First North SwedenTicker: EKOBOTMarket cap at time of publication: 11,3 MSEKStock price at time of publication: 0,782 SEKBusiness: Agtech farming roboticsWebsite: https://www.ekobot.se/ ESGFIRE comment:Ekobot today (30/1) announced a new collaboration agreement with Väderstad AB with the aim to “evaluate the performance of a seed drill using vision technology and artificial intelligence (AI).” The news is exciting for several reasons, firstly because it shows that Ekobot's expertise in the industry regarding vision and AI technology is at the

Katalysen Ventures completes a SEK 10 million directed share issue to strategic, long-term investors

The board of directors of Katalysen Ventures AB (publ) (”Katalysen” or the ”Company”) has today resolved to carry out a directed share issue of 667’169 new shares at a subscription price of SEK 15 per share (“share subscription price”) corresponding to a discount of approximately 13% compared to the the volume-weighted average price (VWAP) for the KAV share over the period 2023-12-29 to 2024-01-30. The total value of the share issue is approximately SEK 10 million before transaction costs. Total transaction costs are estimated at SEK 25’000.The board of directors of Katalysen has today,

Nordea Bank Abp: Repurchase of own shares on 30.01.2024

Nordea Bank AbpStock exchange release – Changes in company’s own shares30.01.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 30.01.2024 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |115,595|11.53 |1,332,821.

Notice of Extraordinary general meeting in Biosergen AB

The shareholders of Biosergen AB, Reg. No. 559304-1295, are invited to attend an extraordinary general meeting to be held on Friday 1 March 2024 at Fogdevreten 2A, SE-171 65 Solna, at 11:00.Right to participate and notice of participationShareholders wishing to participate in the extraordinary general meeting must: · be listed in the company’s share register kept by Euroclear Sweden AB as of 22 February 2024; and, · have given a notice of their intent to participate to the company no later than on 26 February 2024 by e-mail to niels.laursen@biosergen.net. The notification should

Nitro Games signs approx. 3.5 million EUR expansion to the development agreement

Nitro Games has signed an expansion to the development agreement with Digital Extremes to continue the work on Warframe mobile.With this agreement, Nitro Games provides Digital Extremes with game development services for a mobile version of the free-to-play action game, Warframe. This agreement is an expansion to the ongoing order with the same customer, as communicated previously on 1 August 2023. Parallel to this new agreement, Nitro Games has completed the work on the previous project for the same customer, as communicated on 30 July 2021, 26 July 2022, 23 December 2022, and 25 July 2023.

Transaction in Own Shares

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 30 January 2024 REDDE NORTHGATE PLC (“Redde Northgate” or the “Group” or the “Company”)   Transaction in Own Shares   Redde Northgate plc (LSE:REDD) announces that on 30 January 2024 it purchased the following number of its own shares to be held in treasury:   Class of shares :  Ordinary shares of 50p (“shares”)

#24-38 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

#24-37 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

Biosergen carries out a rights issue of units of approximately SEK 40.5 million, and secures bridge loan

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED KINGDOM, THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, HONG KONG, NEW ZEALAND, SINGAPORE, SWITZERLAND, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. The Board of Directors of Biosergen AB (“Biosergen” or the “Company”) has today, subject to approval from a subsequent extraordinary general meeting scheduled to be held on March 1, 2024, resolved to carry out

The Board of Loomis has resolved to repurchase shares

The Board of Directors of Loomis AB has resolved to repurchase shares by virtue of the authorization granted by the annual general meeting 2023.   The repurchase may commence on February 1, 2024, end not later than on April 5, 2024, and comprise an amount up to a maximum of SEK 200 million. The repurchase shall be made on Nasdaq Stockholm, on one or more occasions, at a price within the prevailing price interval registered at each point in time (being the interval between the highest buying price and the lowest selling price). Payment for repurchased shares shall be made in cash.

Age of Wonders 4: Primal Fury to be Unleashed on February 27, 2024

New Culture, New Tomes of Magic, and Wild Beasts Coming Soon to Triumph’s Award-winning Fantasy Strategy GameSTOCKHOLM and DELFT, Netherlands — Jan. 30, 2024 — Paradox Interactive and Triumph Studios today announced the release date for Age of Wonders 4: Primal Fury, a new content pack coming on February 27, 2024 to the award-winning fantasy strategy game for PC, PlayStation 5, and Xbox Series X|S. The studios also revealed the full list of features that will be included with Primal Fury, including a new Primal Culture themed around mastery of beasts and nature, new Tomes of Magic to wield

There are no items matching the current filter
There are no more items matching the current filter
Back to top